-
What the mRNA giants want to tackle most is cancer
Time of Update: 2023-01-06
Back in 2017 Nature has actually reported two positive clinical results based on independent trials of neoantigen cancer vaccines: personalized vaccines tailored to tumor mutations have achieved significant success in the treatment of melanoma patients, but relying on tumor antigen peptide technology.
-
What the mRNA giants want to tackle most is cancer
Time of Update: 2023-01-06
Back in 2017 Nature has actually reported two positive clinical results based on independent trials of neoantigen cancer vaccines: personalized vaccines tailored to tumor mutations have achieved significant success in the treatment of melanoma patients, but relying on tumor antigen peptide technology.
-
What are the latest developments in new molecular treatments such as mRNA, gene editing, and cell therapy
Time of Update: 2022-01-25
The company also announced today a $3 billion R&D collaboration with Century Therapeutics to jointly develop allogeneic cell therapies based on the differentiation of induced pluripotent stem cells (iPSCs), including natural killer cell therapy and T cell therapy .
-
Cell: What makes mRNA vaccines effective against SARS-CoV-2
Time of Update: 2022-01-10
"The longer the T follicle helper cells provide help, the better the antibody, and the more likely you are to have a good memory response," said Philip Mudd, MD, assistant professor of emergency medicine at the University of Washington and co-corresponding author.
-
What are the clinical results of the mRNA vaccine to prevent influenza Moderna?
Time of Update: 2021-12-29
On December 10, 2021, Moderna announced that its Phase 1 clinical trial of the influenza vaccine mRNA-1010 has obtained positive interim data .
"Reference materials:[1] Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update.
-
The revival of therapeutic tumor vaccines! What are the results of the clinical trials of the mRNA vaccine giants?
Time of Update: 2021-11-15
Vaccines against human papillomavirus (HPV) and hepatitis B virus have been successfully applied to the prevention of related tumors . In contrast, the development of therapeutic tumor vaccines is
-
For the entire year, or $82 billion, in addition to mRNA vaccines, what is Pfizer, which has returned to the world's number one, still laying out?
Time of Update: 2021-11-14
In the financial report, Pfizer raised its full-year sales forecast for Comirnaty's new crown vaccine by 7% to approximately US$36 billion .
Pfizer also announced the latest developments in six key R&D pipeline products including the new crown vaccine, gene therapy pipeline, PDE4 inhibitor, TL1A inhibitor, IFN-β inhibitor and oral COVID-19 drugs .
-
What is Pfizer still planning to return to the world's No. 1 mRNA vaccine?
Time of Update: 2021-11-14
In the financial report, Pfizer raised its full-year sales forecast for Comirnaty's new crown vaccine by 7% to approximately US$36 billion .
Pfizer also announced the latest developments in six key R&D pipeline products including the new crown vaccine, gene therapy pipeline, PDE4 inhibitor, TL1A inhibitor, IFN-β inhibitor and oral COVID-19 drugs .
-
The revival of therapeutic tumor vaccines! What are the results of the clinical trials of the mRNA vaccine giants?
Time of Update: 2021-11-04
Article source: MedAuthor: Ala LeiVaccines against human papillomavirus (HPV) and hepatitis B virus have been successfully applied to the prevention of related tumors . In contrast, the development o
-
What is the effect of the fire mRNA new crown vaccine?
Time of Update: 2021-10-01
"Sette said that this new study shows a strong CD8+ T cell response to the low-dose Moderna Covid-19 vaccine, similar to the response of patients to natural SARS-CoV-2 infection .
-
What are the mRNA drugs for the treatment of tumors and rare diseases?
Time of Update: 2020-12-26
RG-6180 is a personalized mRNA-based cancer vaccine that encodes specific tumor-specific antigens in patients' tumors for intravenous drugging to treat solid tumors, including melanoma, non-small cell lung cancer (NSCLC), pancreatic cancer, and colorectal cancer.